European Journal of Medicinal Chemistry p. 1 - 13 (2017)
Update date:2022-08-11
Topics:
Labrière, Christophe
Gong, Huansheng
Finlay, B. Brett
Reiner, Neil E.
Young, Robert N.
Several novel series of compounds were synthesized and evaluated as inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase (PK). PK has been identified as a highly interconnected essential ‘hub’ protein in MRSA, with structural features distinct from the human homologs which makes it a novel antimicrobial target. Several MRSA PK inhibitors (including the hydrazide 1) were identified using in silico screening combined with enzyme assays and were found to be selective for bacterial enzyme compared to human PK isoforms. Structure–activity relationship (SAR) studies were carried out on the replacement of the hydrazide linker with 3-atoms, 2-atoms and 0-atom linkers and led us to discover more potent compounds with enzyme inhibiting activities in the low nanomolar range and some were found to effectively inhibit bacteria growth in culture with minimum inhibitory concentrations (MIC) as low as 1?μg/mL.
View Morewebsite:http://www.josunpharma.com
Contact:+86-311-80715268 80766839
Address:No.39, Zhaiying Street, Shijaizhuang,Hebei,China
Airsea(Taizhou) Pharmaceutical Limited
Contact:+86-576-88057622
Address:Dubei, Duqiao, Linhai, Taizhou, Zhejiang, China Zip: 317016
Contact:(1) 206-3550089
Address:5115 NE 8TH PL, Renton, WA 98059 USA
Jinan Jianfeng Chemical Co., Ltd
Contact:0086-531-88110457
Address:sales01(-a-t-)pharmachemm{dot}c+o+m
Anhui Qingyun Pharmaceutical and Chemical Co.,Ltd
Contact:+86-551-63633067
Address:Shuangfeng Road Hefei Anhui
Doi:10.1016/j.tet.2006.11.079
(2007)Doi:10.1016/S0031-9422(00)83185-4
(1985)Doi:10.1016/j.jorganchem.2017.03.051
(2017)Doi:10.1021/jo010611p
(2002)Doi:10.1002/chem.201403648
(2014)Doi:10.1002/jhet.5570260656
(1989)